Why (not) go east? Comparison of findings from FDA Investigational New Drug study site inspections performed in Central and Eastern Europe with results from the USA, Western Europe, and other parts of the world
Open Access
- 1 March 2012
- journal article
- research article
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. 6, 53-60
Abstract
Peer reviewed article authored by (Caldron PH, Gavrilova SI, Kropf S). Read article or submit your manuscript for publishing.Keywords
This publication has 3 references indexed in Scilit:
- Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the member states relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use.2005
- Clinical trials in Russia and Eastern Europe: Recruitment and qualityInt. Journal of Clinical Pharmacology and Therapeutics, 2003
- The pharmaceutical industry and oncology in Central and Eastern EuropeAnnals of Oncology, 1999